Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Pro-Dex Inc. | 12 | 0 | 2 | 0 | €27.40 | €27.17 | -0.836% |
| Dynavax Technologies Corp | 4 | 0 | 0 | 0 | €10.29 | €26.95 | 161.902% |
| Exelixis Inc. | 22 | 0 | 4 | 0 | €23.95 | €26.01 | 8.586% |
| Catalyst Pharmaceutical Partners Inc | 15 | 0 | 1 | 0 | €18.22 | €25.69 | 41.029% |
| Adverum Biotechnologies Inc. | 10 | 0 | 0 | 0 | €1.38 | €25.32 | 1734.529% |
| Iovance Biotherapeutics Inc. | 17 | 0 | 0 | 0 | €9.54 | €25.20 | 164.291% |
| Deciphera Pharmaceuticals | 6 | 0 | 0 | 0 | €23.80 | €24.97 | 4.929% |
| Enanta Pharmaceuticals Inc. | 6 | 2 | 1 | 0 | €9.85 | €24.75 | 151.251% |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Myriad Genetics | 4 | 3 | 0 | 0 | €23.80 | €22.15 | -6.944% |
| Novavax Inc. | 6 | 1 | 1 | 0 | €12.40 | €21.98 | 77.162% |
| Tactile Systems Technology Inc | 3 | 0 | 3 | 0 | €12.60 | €20.62 | 63.647% |
| Evolus Inc | 17 | 0 | 6 | 0 | €15.20 | €20.46 | 34.620% |
| Stoke Therapeutics Inc | 15 | 1 | 1 | 0 | €11.00 | €20.40 | 85.460% |
| Hutchison China MediTech Ltd ADR | 3 | 0 | 0 | 0 | €18.00 | €20.23 | 12.391% |
| Teladoc Health Inc | 15 | 0 | 0 | 0 | €8.24 | €19.96 | 142.133% |
| Teva Pharmaceutical Industries Ltd ADR | 20 | 0 | 1 | 0 | €15.95 | €19.37 | 21.445% |
| Kezar Life Sciences | 6 | 0 | 0 | 0 | €0.76 | €18.35 | 2329.801% |
| Amicus Therapeutics Inc. | 9 | 0 | 2 | 0 | €9.45 | €17.63 | 86.582% |
| Elanco Animal Health Inc. | 10 | 2 | 2 | 0 | €13.11 | €17.10 | 30.470% |
| R1 RCM Inc. | 21 | 0 | 0 | 0 | €12.70 | €16.89 | 32.987% |
| scPharmaceuticals | 2 | 0 | 0 | 0 | €3.90 | €16.44 | 321.454% |
| Verastem Inc. | 14 | 0 | 1 | 0 | €2.62 | €16.10 | 514.538% |
| Emergent Biosolutions Inc. | 8 | 1 | 1 | 0 | €8.51 | €14.36 | 68.626% |
| Abeona Therapeutics Inc. | 7 | 1 | 2 | 0 | €5.90 | €13.92 | 135.907% |